The latest news and breakthrough developments from the field of cancer research. We bring you the latest updates from organisations looking into diagnosing and treating all types of cancers using the latest scientific advancements and what is being done to improve patient care.
The NHS will provide a life-extending prostate cancer drug to thousands of men in England, expanding access to a treatment clinically proven to improve survival rates.
Through world-class research, we can better understand and tackle the impacts of cancer inequalities to ensure we are beating cancer for everyone. Experts from Cancer Research UK explain.
Gastric cancer is the fifth most common cancer, yet research and prevention efforts remain limited. Lorna Rothery spoke with Dr Jin Young Park, the leader of the Gastric Cancer Prevention Team at the International Agency for Research on Cancer, about the necessary steps for improvement.
Prebo Barango, Co-chair of the UN Joint Action Group for the Cervical Cancer Elimination Initiative at the World Health Organization (WHO), and Nicholas Banatvala, Head of the Secretariat for the UN Interagency Task Force on the Prevention and Control of Noncommunicable Diseases, discuss the challenges and progress in the efforts to eliminate cervical cancer.
Scientists at UCL and GOSH have used groundbreaking base-edited CAR‑T cell therapy — BE‑CAR7 — to treat aggressive T‑cell leukaemia, with two‑thirds of patients now disease‑free.
A new immunotherapy for a severe form of blood cancer will soon be available on the NHS, offering new hope to adults whose disease has returned or stopped responding to conventional treatment.
The Global Alliance for Genomics and Health (GA4GH) is uniting researchers worldwide to share genomic data responsibly, set open standards, and improve oncology care. Leaders from its Cancer Community discuss the current state of cancer genomics and where the field is headed.
Oxford University and GSK launch a £50 million experimental medicine programme aiming to train the immune system to prevent cancer, paving the way for breakthrough vaccines and early‑stage treatments.
Cancer Research UK is backing a £2.06 million, first-in-human trial of LungVax, a preventative vaccine designed to prime the immune system against early lung cancer.
The TAR‑200 slow‑release bladder implant cleared tumours in 82% of patients with high‑risk non‑muscle‑invasive bladder cancer, offering a promising new treatment approach.
